Importantly, the concentration range in which aripiprazole enhanced mutant ATXN3-mediated motor phenotype is potentially relevant in the clinical context, as previous imaging studies found analogous concentrations of this compound in the brain of schizophrenia patients [77]. The gene discussed is ATXN3; the disease is schizophrenia.